cc100

Cell therapyexperimental

Clinical trial activity

2 trials · 2 clinical orgs · 0 marketing orgs

Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0

Earliest trial started Nov 1, 2013 (NCT02050334)

Timeline

2010s

  1. Jan 1, 2013

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetTissue restoration

    tissue restoration

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • cc100

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT03049046Phase 1Apr 7, 2017Chemigen, LLC
NCT02050334Phase 1Nov 1, 2013Chemigen, LLC, Indiana University
Showing 2 of 2 trials
Page 1 / 1

Organizations

Research & Development (2)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Chemigen, LLCFor profit2212013
Indiana UniversityAcademic/Hospital1012013
2 organizations
Page 1 / 1